基础医学与临床 ›› 2018, Vol. 38 ›› Issue (3): 375-380.

• 研究论文 • 上一篇    下一篇

基于CRISPR/Cas9系统的HEK293T细胞DMD基因第51号外显子的靶向敲除

李双1,马珊珊2,崔思颖1,屈素真1,蔡奥捷1,关方霞2,孔祥东1   

  1. 1. 郑州大学第一附属医院
    2. 郑州大学
  • 收稿日期:2017-09-05 修回日期:2017-12-08 出版日期:2018-03-05 发布日期:2018-02-27
  • 通讯作者: 孔祥东 E-mail:kongxd@263.net
  • 基金资助:
    2016年度河南省产学研合作项目

Targeting knockout of DMD gene exon51 in HEK293T cell based on CRISPR/Cas9 system

  • Received:2017-09-05 Revised:2017-12-08 Online:2018-03-05 Published:2018-02-27

摘要: 目的 应用CRISPR/Cas9基因编辑技术,完成HEK293T细胞中DMD基因51号外显子(exon51)高效的靶向敲除。 方法 设计靶向人DMD基因exon51 5’端及3’端的sgRNA并克隆至CRISPR/Cas9载体质粒PX459中,转染至HEK293T细胞后,提取基因组DNA并使用Surveyor法检测切割活性;使用目标外显子两端切割活性最高的sgRNA构建PX459-2sgRNA质粒,转染至HEK293T细胞后用PCR及T载体测序检测靶向外显子切除情况。 结果 50%的HEK293T细胞中DMD基因exon51被定向切除,编辑效率较高。 结论 建立使用CRISPR/Cas9单质粒敲除人DMD基因exon51的平台,为DMD及其他遗传病的基因治疗研究奠定实验基础。

关键词: CRISPR/Cas9, DMD基因, 单载体质粒, HEK293T细胞, 外显子敲除

Abstract: Objective To target knockout the exon51 of DMD gene in HEK293T cells using the CRISPR/Cas9 system. Methods Design the target sequences of sgRNA and clone them into plasmid PX459 respectively; transfer these plasmids into HEK293T cell and extract the total genome DNA; test the activity of sgRNAs with surveyor assay, choose the most efficient one in each end; construct plasmid PX459-2sgRNA and transfer it into HEK293T cells; check whether the exon51 has been knocked known with PCR and T vector sequencing. Results 50% of HEK293T cells’ DMD gene exon51 were knocked out, showing a high gene editing efficiency. Conclusion Successfully establish a platform to target knockout the exon51 of DMD gene, provide an important experimental basis for the treatment of DMD and other genetic diseases.

Key words: CRISPR/Cas9, DMD gene, single vector plasmid, HEK293T cell, exon knockout

中图分类号: